GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk : vi

A cohort study in three Scandinavian countries found no significant increase in thyroid cancer risk with glucagon-like peptide 1 receptor agonists.

Related Keywords

Denmark , Sweden , Stockholm , Norway , Karolinska Institutet , , Thyroid Cancer , Thyroid Carcinoma , Ancer Of The Thyroid , Thyroid Disorder , Thyroid Disease , Thyroid Dysfunction , Malignant Head And Neck Neoplasm , Head And Neck Cancer , Ead And Neck Cancer Hnc , Papillary Carcinoma Of The Thyroid , Papillary Thyroid Carcinoma , Cancer Risk , Cancer , Alignant Neoplasia , Arcinoma , Alignant Neoplasm , Thyroid , Glp 1 Receptor Agonists ,